Niagen Bioscience (NAGE) Cash from Operations Growth (1y) (2012 - 2026)
Niagen Bioscience (NAGE) Cash from Operations Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - | - |
| 10 | Niagen Bioscience | 258.53 Mn | 191.98 Mn | 19.98 Mn | -115.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -115.15% |
| Dec 31, 2025 | -91.80% |
| Sep 30, 2025 | 5.87% |
| Jun 30, 2025 | 560.98% |
| Mar 31, 2025 | 2,572.20% |
| Dec 31, 2024 | 1,222.50% |
| Sep 30, 2024 | 782.58% |
| Jun 30, 2024 | -108.05% |
| Mar 31, 2024 | -89.43% |
| Dec 31, 2023 | 297.87% |
| Sep 30, 2023 | 110.59% |
| Jun 30, 2023 | 185.59% |
| Mar 31, 2023 | 138.79% |
| Dec 31, 2022 | 93.37% |
| Sep 30, 2022 | 36.81% |
| Jun 30, 2022 | 51.46% |
| Mar 31, 2022 | -33.17% |
| Dec 31, 2021 | -22,572.73% |
| Sep 30, 2021 | -53.94% |
| Jun 30, 2021 | -407.39% |